Georgia Tech’s College of Engineering offers the resources of a major technological university and a location in the heart of cosmopolitan Atlanta. The College is the largest of the Institute’s six colleges, enrolling more than 60 percent of the students at Georgia Tech and about half of all tenured and tenure track faculty at the Institute. U.S. News and World Report ranks the College in the top four of engineering programs in the country. The College offers more than 50 different degree programs at the bachelor’s, master’s, and doctoral levels through its main Atlanta campus and satellite campuses around the world. As a leader in engineering education, the College graduates the largest number of women and minority engineers in the country. Visit www.coe.gatech.edu to learn more. 

Georgia Tech College of Engineering

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Atlanta Business Chronicle Healthcare Hero Award (Rising Star)

Emory School of Medicine Hidden Gem Award

Fellow of the American Heart Association

Melvin L. Marcus Young Investigator Award in Cardiovascular Science Finalist (American Heart Association)

Children's Heart Research and Outcomes (HeRO) Center

Predicting Functional Responses of Progenitor Cell Exosome Potential with Computational Modeling

Using Statistical Modeling to Understand and Predict Pediatric Stem Cell Function

Electrospun Nanofiber-Based Patches for the Delivery of Cardiac Progenitor Cells

Efficient Energy Gradient Calculations for Binary and Polyphase Sequences

Coherent MIMO Radar: the Phased Array and Orthogonal Waveforms

Stem Cell Therapy

Cardiac Regeneration

Bioengineering Profile

Petit Institute Profile

Biomedical Engineering Profile

The Davis Lab

Emory University Profile

Google Scholar Profile

Targeted delivery of biological factors using self-assembling peptide nanofibers

crispr-is-the-genetic-game-changer-but-are-we-ready

Professor, Associate Chair for Graduate Studies, Biomedical Engineering

CRISPR is here to stay – and the daily advances of this technology and stem cell therapy seem to be moving at a near exponential speed. “CRISPR Therapeutics of Zug, Switzerland, reported that one patient with sickle cell anemia and another with beta thalassemia appear to have benefited from the same CRISPR-based intervention for up to 9 months, STAT reports. (The company gave STAT an early look at the data but did not allow outside commenters to see the results.) Before the treatment, both patients required multiple infusions each year of red blood cells. CRISPR Therapeutics, collaborating with Vertex Pharmaceuticals, removed blood stem cells from their bodies and modified them with CRISPR to knock out a gene that shuts down production of fetal hemoglobin. When the edited cells were put back in each patient’s body through a stem cell transplant—which required a toxic chemotherapy to kill their own stem cells—both people produced high levels of fetal hemoglobin and no longer needed transfusions.” November 19 – Science Mag  CRISPR and how it will shape the future of genetics, health care and society are the subject of great debate, hope and concern and if you are a journalist covering this topic and need an expert source for insight and perspective – let us help.  Dr. Michael Davis researches cardiac regeneration, stem cell therapy and preservation at the Georgia Tech College of Engineering where he also is the Associate Chair for Graduate Studies in Biomedical Engineering. Michael is available to speak to media regarding this topic, simply click on his icon to arrange an interview. 

Select Inquiry Type